When drug companies select what they want to publish patients are denied relevant therapeutic information-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

When drug companies select what they want to publish patients are denied relevant therapeutic information

Published:2008-07-16 Issue:3 Volume:3 Page:255-257
ISSN:1828-0447
Container-title:Internal and Emergency Medicine
language:en
Short-container-title:Intern Emerg Med

Author:

Filippini Graziella,Moja Lorenzo,Liberati Alessandro,Gensini Gian Franco,Gusinu Roberto,Conti Andrea A.

Publisher

Springer Science and Business Media LLC

Subject

Emergency Medicine,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11739-008-0174-7.pdf

Reference17 articles.

1. Goodin DS, Frohman EM, Garmany GP Jr et al (2002) Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology; MS Council for Clinical Practice Guidelines. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 58:169–178

2. Multiple Sclerosis Therapy Consensus Group (2004) Escalating immunotherapies of multiple sclerosis. J Neurol 251:1329–1339

3. Freedman MS, Blumhardt LD, Brochet B, Comi G, Noseworthy JH, Sandberg-Wollheim M, et al. Paris Workshop Group (2002) International consensus statement on the use of disease-modifying agents in multiple sclerosis. Mult Scler 8:19–23

4. Filippini G, Munari L, Incorvaia B, Ebers GC, Polman C, D’Amico R, Rice GP (2003) Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet 361:545–552 Cochrane Review

5. Montori VM, Guyatt GH (2001) Intention-to-treat principle. CMAJ 165:1339–1341

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The conundrum of iron in multiple sclerosis – time for an individualised approach;Metabolic Brain Disease;2012-03-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3